Ultrasonic Nebulizer Market: Current Analysis and Forecast (2022-2030)

Ultrasonic Nebulizer Market: Current Analysis and Forecast (2022-2030)

The ultrasonic nebulizer market has witnessed significant growth in the healthcare industry and continues to be a prominent segment within the healthcare industry. Ultrasonic nebulizers are medical devices that use ultrasonic waves to convert liquid medication into fine mist, making it easier for patients to inhale and deliver the medication directly to their respiratory system. This technology has gained popularity due to its efficiency, portability, and ease of use. The global demand for ultrasonic nebulizers is increasing due to the rise in the geriatric population and the increasing prevalence of chronic respiratory disorders among them. For instance, as per Medscape, the prevalence of COPD in individuals 65 years of age and older is estimated to be 14.2%. Further, the technological advancements and rising involvement of major players in medical technologies are also attributing factors for the market growth of ultrasonic nebulizers.

Ultrasonic Nebulizer Market is expected to grow at a strong CAGR of 5.2% during the forecast period owing to increasing research efforts on the Ultrasonic Nebulizer.

• On the basis of type, the market is segmented into large-volume ultrasonic nebulizers and small-volume ultrasonic nebulizers. The small-volume ultrasonic nebulizers segment held a dominant share of the market in 2021 mainly due to the surging demand for portable healthcare devices that can be used at homes and the emergency departments in hospitals. Further, these nebulizers are more user-friendly and can be used for medicine delivery in children is also an important reason for the market growth of the segment.
• On the basis of application, the market is segmented into chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma, and others. The asthma segment is expected to witness major growth during the forecast period due to the increasing patient pool suffering from asthma all over the world as they require regular monitoring of their dosage intake. For instance, according to the Asthma and Allergy Foundation of America, in 2023, patients with asthma reported 11 million visits to a doctor’s office and 1.7 million visits to hospital outpatient departments. In 2019, 455 000 people died and 262 million people were affected by asthma by the report of WHO in 2023.
• On the basis of end-user, the market is segmented into hospitals & clinics, emergency centers, and home healthcare. The hospitals & clinics held the dominant share of the market in 2021 owing to the presence of therapeutic and critical care products. Moreover, the presence of skilled professionals who are responsible for developing and implementing treatment plans for patients with respiratory disorders. In 2022, asthma will be the cause of 439,000 hospital admissions and 1.3 million visits to the emergency room, according to the CDC. Thus, these above-mentioned factors are driving the growth of the segment in the forecast period.
• For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. The growing demand for ultrasonic nebulizers can be attributed due to the surge in the prevalence of respiratory disorders and the continuously rising geriatric population in the region. Further, the increased consumption of alcohol and smoking are other important factors responsible for the market growth of ultrasonic nebulizers in the North American region.
• Some of the major players operating in the market include PARI GmbH; Koninklijke Philips N.V.; OMRON Healthcare, Inc; Invacare Corporation; Beurer GmbH; Medline Industries, LP; Medical Depot, Inc.; GF Health Products, Inc.; Besmed Health Business Corp; and Kare Medical and Analytical Devices Ltd. Co.

"The ultrasonic nebulizer market was valued at USD 173 Million and is expected to grow at a strong CAGR of 5.2% during the forecast period (2022-2030). Nebulizers are medical devices that are used to deliver medications in the form of mist from liquid form into the lungs. An ultrasonic nebulizer uses ultrasound waves to convert medication into mist form. The increased incidences of infectious diseases among children and their effect on the respiratory system are among the main reasons that are responsible for the market growth of ultrasonic nebulizers. For instance, according to UNICEF, globally, pneumonia occurs in more than 1,400 cases per 100,000 children, or 1 in 71 children, with the highest incidence in South Asia, West and Central Africa.

Some of the major players operating in the market PARI GmbH; Koninklijke Philips N.V.; OMRON Healthcare, Inc; Invacare Corporation; Beurer GmbH; Medline Industries, LP; Medical Depot, Inc.; GF Health Products, Inc.; Besmed Health Business Corp; and Kare Medical and Analytical Devices Ltd. Co. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst type, the small-volume ultrasonic nebulizers segment is expected to grow at a higher CAGR during the forecast period.”

On the basis of type, the market is segmented into large-volume ultrasonic nebulizers and small-volume ultrasonic nebulizers. As per our analysis, the small-volume ultrasonic nebulizers segment is expected to grow at a higher CAGR during the forecast period. The demand for small-volume ultrasonic nebulizers is the increasing prevalence of respiratory diseases worldwide. According to the World Health Organization (WHO), over 339 million people suffer from asthma, and COPD is the third leading cause of death globally. As a result, there is a growing need for efficient and convenient drug delivery systems, leading to the adoption of small-volume ultrasonic nebulizers. The compact size and portability of small-volume ultrasonic nebulizers make them highly desirable for patients who require regular and on-the-go medication administration.

“Amongst applications, the asthma segment held the dominant share in 2021.”

On the basis of application, the market is segmented into chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma, and others. asthma segment held the dominant share in 2021. The presence of large number of asthma cases globally is the major reason for the large share of the segment in the ultrasonic nebulizer market. For instance, according to the World Health Organization, Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths.

“Amongst end-users, the home healthcare segment is expected to grow at a higher CAGR during the forecast period.”

On the basis of end-user, the market is segmented into hospitals & clinics, emergency centers, and home healthcare. As per our analysis, the home healthcare segment is expected to grow at a higher CAGR during the forecast period. In addition, some of the high-impact rendering drivers for home healthcare devices are anticipated to be the growing geriatric population, the high incidence of target diseases, and the growing need to reduce healthcare expenditure. The Ultrasonic nebulizer market is anticipated to grow as the cost-effective alternative to costly hospital stays is home healthcare.

“Asia Pacific is expected to grow with the highest CAGR Ultrasonic Nebulizer market during the forecast period.”

Asia Pacific is expected to grow with the highest CAGR ultrasonic nebulizer market during the forecast period due to its large population and the increasing geriatric population in the region attributed to the market growth in the region. For instance, as per the European Parliament, Japan is aging rapidly. Its "aging" society is the oldest in the world, 28.7% of the population is over the age of 65 and women make up the majority.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.